Edema News and Research RSS Feed - Edema News and Research

Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.
Scientists identify potential drug for pre-treating cells that swell after mild traumatic brain injury

Scientists identify potential drug for pre-treating cells that swell after mild traumatic brain injury

A team of biomedical engineering researchers at the University of Arkansas have identified a cause of fluid swelling of the brain, or cellular edema, that occurs during a concussion. [More]
Mayo launches new High Altitude and Harsh Environments Medical Clinic

Mayo launches new High Altitude and Harsh Environments Medical Clinic

Mayo Clinic is seeing patients with concerns about traveling to high altitudes at the recently established High Altitude and Harsh Environments Medical Clinic. [More]
Climbing Mount Kilimanjaro to research oxygen deprivation

Climbing Mount Kilimanjaro to research oxygen deprivation

This expedition was a part of our clinical collaboration with the Mayo Clinic. In short, this particular study focused on the effect of altitude and aging on heart and lung function. [More]
Discovery of neuropilin 2 deficiency may lead to new therapies for edema and lymphedema

Discovery of neuropilin 2 deficiency may lead to new therapies for edema and lymphedema

Fluid accumulation and swelling (edema) may result from the malfunctioning of regulatory processes controlling vessel permeability in the body. [More]
Study explores antimicrobial and antiinflammatory activities of bovine colostrum

Study explores antimicrobial and antiinflammatory activities of bovine colostrum

Colostrum is a thick, sticky, yellowish mammary secretion that all mammals provide to their newborns during the first 24-48 hours after delivery. [More]
Study shows retinoic acid could prevent postsurgical lymphedema

Study shows retinoic acid could prevent postsurgical lymphedema

A study conducted at the Keck School of Medicine of the University of Southern California showed that 9-cis retinoic acid (alitretinoin) could significantly prevent postsurgical lymphedema. [More]
Research offers new insights into underlying mechanisms of deadly cystic fibrosis

Research offers new insights into underlying mechanisms of deadly cystic fibrosis

A minor hiccup in the sequence of a human gene can have devastating impacts on health. Such flaws cause cystic fibrosis (CF), a disease affecting the lungs and other vital organs, often leading to death by the age of 30. [More]
Researchers reveal potential therapeutic treatment for alphavirus infections

Researchers reveal potential therapeutic treatment for alphavirus infections

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment for the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus (RRV) and Chikungunya Virus (CHIKV). [More]
Pre-travel consultation can help international travelers to prepare for trip

Pre-travel consultation can help international travelers to prepare for trip

International tourism exceeds 1.2 billion persons each year, with more than 20 percent of travelers reporting some type of illness. [More]
Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Simple diagnostic algorithm to assess pulmonary embolism risk can help reduce rate of CTPA imaging

Patients with suspected pulmonary embolism (PE) often undergo computed tomography pulmonary angiography (CTPA) to confirm or exclude the diagnosis. [More]
REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

A clinical decision rule (CDR) that can be applied to women after a first, unprovoked venous thromboembolism (VTE) was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016. [More]
New series of treatments may provide another option for families of unborn babies with CPAM

New series of treatments may provide another option for families of unborn babies with CPAM

A medical team at Osaka University Hospital, Japan, has conducted successful treatment for the fetal lung disorder Congenital Pulmonary Airway Malformattion (CPAM), also known as Congenital Cystic Adenomatoid Malformation (CCAM). [More]
IU researchers create virtual tissue model of diabetic retinopathy

IU researchers create virtual tissue model of diabetic retinopathy

By combining data on optometry patient's eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye. [More]
New, minimally invasive procedure may be effective for patients with FED

New, minimally invasive procedure may be effective for patients with FED

A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea transplant. [More]
European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year. [More]
Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Anthrax capsule vaccine offers protection from deadly anthrax infection in monkeys

Vaccination with the anthrax capsule--a naturally occurring component of the bacterium that causes the disease--completely protected monkeys from lethal anthrax infection, according to a study published online this week in the journal VACCINE. [More]
Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease. [More]
Blocking IL-1 signalling molecule could alleviate asthma symptoms

Blocking IL-1 signalling molecule could alleviate asthma symptoms

Scientists have made a discovery that could lead to improved treatment for asthma sufferers.They have found that blocking a certain signalling molecule can alleviate symptoms such as mucus production, swelling (edema), and constriction of the airways in the lungs. [More]
Scientists develop new drug for life-threatening lung disease treatment

Scientists develop new drug for life-threatening lung disease treatment

Researchers are developing a new drug to treat life-threatening lung damage and breathing problems in people with severe infections like pneumonia, those undergoing certain cancer treatments and premature infants with underdeveloped, injury prone lungs. [More]
Professor outlines effects of sports-specific counseling on injury outcomes in youth athletes

Professor outlines effects of sports-specific counseling on injury outcomes in youth athletes

Neeru Jayanthi, MD, Associate Professor of Orthopedics and Sports Medicine at Emory University Sports Medicine Center in Atlanta, GA, presented "The Effects of Serial Sports Training Risk Assessment and Counseling in Kids (T.R.A.C.K.)" at the 25th Annual Meeting of the American Medical Society for Sports Medicine in Dallas, TX. [More]
Advertisement
Advertisement